– ISRAEL, Hod Hasharon – BATM Advanced Communications Limited (TASE: BVC | LON: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, today announced the appointment of Dr. Avigdor Shafferman to its Board as a Non-Executive Director with immediate effect.
“I would like to welcome Avigdor back to BATM. He made an excellent contribution to our business previously and we look forward to once again being able to leverage his wealth of knowledge and experience as we continue to advance our leading-edge medical diagnostics solutions.” said Board Chairman, Dr. Gideon Chitayat.
About Dr. Avigdor Shafferman
Dr. Avigdor Shafferman had an established career at the Israel Institute for Biological Research, a leading governmental applied research institute specializing in the fields of biology, medicinal chemistry, and environmental sciences, where he worked for almost 40 years. Most recently, from 1995 until his retirement in 2013, he was General Director of the organization. Other roles have included serving as a visiting professor at the University of California, San Diego in the biology department as well as a visiting senior research scientist at various leading research institutions in the United States in various medical areas, including vaccines. Dr. Shafferman holds a Ph.D. in physical chemistry from the Hebrew University of Jerusalem.
Previously, Dr. Shafferman served as an external director of the Group from February 2015 to February 2018.Wit h his new appointment as a Non-executive Director, Dr. Shafferman will be subject to annual re-election at the Group’s annual general meeting.
For more information: https://www.batm.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
